-
Griffin's Blue Ridge Capital 13F Shows New MasterCard (MA), Visa (V) Stakes (more...)
-
Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
-
Pre-Open Stock Movers 3/11: (LJPC) (BYD) (FCEL) Higher; (FTEK) (RTK) (MYGN) Lower (more...)
-
Notable Analyst Rating Changes 02/05: (AGNC) (HIG) (VALE) Upgraded; (BBG) (SIRI) (RPTP) Downgraded
-
Notable Analyst Rating Changes 08/14: (SINA) (HOV) (MWE) Upgraded; (ARO) (MYGN) (PRXL) Downgraded
-
StreetInsider.com Pre-Open Movers 02/06: (SFLY) (GDP) (MUSA) Higher; (CHRW) (DWA) (GME) Lower (more...)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Notable Analyst Rating Changes 05/04: (FSLR) (SNY) (FE) Upgraded; (MEE) (NSC) (MYL) Downgraded
-
Notable Analyst Rating Changes 02/23: (AMAT) (AKS) (YOKU) (HOC) Upgraded; (NFLX) (FRX) (MDT) (MRO) Downgraded
-
Daily State of the Markets 01/28: Big, Round Numbers
-
Notable Analyst Rating Changes 08/11: LDK, BPO, SPWRA, NRGY Upgraded; MYGN, PBR, TWTC, TSCO Downgraded
-
Citi Moves Myriad Genetics (MYGN) to 'Hold/High Risk'; Over-Reliance on BRACAnalysis
-
Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
-
Citi 2010 Healthcare Conference Key Takeaways - MRK, PFE, BMY, ISIS, NPSP, & MYGN
-
Unusual 11 Mid-Day Movers 5/5: PCBC, CSPI, AMMD, TX, ESE Higher; ITMN, MYGN, LNCE, CLMT Lower
-
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded
-
Citigroup Downgraded Myriad Genetics (MYGN) to Hold
-
Notable Analyst Rating Changes 1/12: PG, MGM, DPZ, CMA, QLGC, WGOV Upgraded; CL, GPS, NWY, PMCS, LEAP, MYGN Downgraded
-
David Moenning's Daily State of the Markets: 8/26
-
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded
-
Unusual 11 Mid-Day Movers 7/1: OSK, BORL, UIS, SDTH Higher; BEAT, FRPT, RPRX, SPAR Lower
-
Notable Analyst Rating Changes 7/1: YUM, TRW, MGA, MVL Upgraded; FRPT, NDAQ, BEAT, MYGN Downgraded
-
Morning Movers 7/1: OSK, BORL, CBL, LNN Higher; BEAT, FRPT, GSIG, MYGN, IMMR Lower
-
Citi Maintains a 'Buy' on Myriad Genetics (MYGN); Sell-Off Overdone - Presents Buying Opportunity
-
Citi Upgrades Myriad Genetics (MYGN) to Buy
-
David Moenning's Daily State of the Markets: 11/04
-
Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
-
Equity option family volume leaders in first 30-minutes of Trading: C WB MYGN RIMM
-
Pre-Open Movers 6/30: H&R Block (HRB) Up on Results/Guidance; Myriad Genetics (MYGN) Lower on Drug Failure
-
Citi Maintains 'Hold' Rating on Myriad Genetics (MYGN)
-
Pre-Open Movers: Thornburg Mortgage (TMA) Sinks After Failing To Meet Margin Call, Blockbuster (BBI) Up on Results

